The planned area of the marine biology and medical care and health industry cluster area is 23 square kilometers. The agglomeration area has a number of national signs such as the "National Torch Program Marine Biology and Pharmaceutical Characteristic Industrial Base", and has cultivated a number of industry-leading enterprises and key enterprises in subdivision fields such as Luye Pharmaceutical, Rongchang Pharmaceutical, and CSPC. There are 3 comprehensive new drug research and development technology platform demonstration enterprises, 1 national-level enterprise technology center, and 19 provincial-level enterprise technology centers.
1. Location
The area is located in the east of Taipei Middle Road, west of Huandao Road, south of Yugang Road, and north of Baiyinhe in Yantai Economic and Technological Development Zone, with a net area of 3.15 square kilometers.
2. Development goals
Strive to build a nationally leading and globally influential marine biology and medical health industry cluster area, and gradually cultivate and expand the advantages of biomedicine, medical equipment, health products, marine biological enzyme preparations, marine green agricultural biological preparations, and marine biological functional materials industry. It is estimated that the industrial scale will reach 10 billion yuan in 2022 and reach 20 billion yuan in 2025.
Three, investment direction
1. Biomedicine industry chain. Focus on attracting, cultivating and developing high-end preparations and new antibody drugs based on new therapeutic targets, and building long-acting and targeted high-end preparations and new antibody technology platforms such as ADCs and bifunctional antibodies; long-acting genetic recombinant protein drugs and multi-linked multivalent vaccines , Genetic engineering vaccines, viral vector vaccines, nucleic acid vaccines and other new vaccines.
2. Medical device industry chain. Focus on attracting, cultivating and developing in vitro diagnostic products with core technologies and great clinical value, including high-throughput biochemical analysis, immunoassay, molecular diagnostic instruments and related reagents; used for oral repair, skin repair, ligament repair, bone repair and nerve repair Various new types of tissue repair materials.
3. The industry chain of health products. Focus on attracting, cultivating and developing health drinks, marine biological preparations, and marine health foods.
4. High-tech pharmaceutical R&D and industrialization service outsourcing industry chain. Focusing on high-end preparations, new antibodies and other fields, focus on attracting, fostering and developing a number of high-level, international comprehensive biomedical contract R&D and production service platforms.
5. Marine biological industry chain. Focus on attracting, cultivating and developing marine biological enzyme preparations, marine green agricultural biological preparations, and marine biological functional materials manufacturing industries.
Fourth, investment advantage
High-end innovation incubation carriers such as the National Torch Biology and New Pharmaceutical Characteristic Industrial Base, the National Innovative Drug Incubation Base, and the Provincial High-tech Biological Industry Base have been established in the agglomeration area, and have cultivated Rongchang Pharmaceutical, Dongcheng Pharmaceutical, Maibury, Simcere A group of leading enterprises in the industry and key enterprises in sub-fields, including biopharmaceuticals, medical devices, diagnostic reagents and vaccines, modern Chinese medicine, biological health products, and other fields. Continue to strengthen the "elements follow the project", give priority to guaranteeing access to the world's top 500 parks, industry engine project land indicators, and construction funding needs. The infrastructure in the area is mature and complete, and the park projects "get land and start".
1. Location
The area is located in Yantai High-tech Industrial Development Zone, with Binhe West Road in the east, Bosna Road in the west, Hangtian Road in the north, and the district boundary in the south, with a net area of 6.95 square kilometers.
2. Development goals
Strive to land a Fortune 500 company by 2022, introduce 3-5 leading projects, and strive to achieve an output value of more than 5 billion yuan; in 2025, a marine biology and medical health industry cluster will be formed, and the industry chain will extend to the mid-to-high end and strive for a breakthrough in output value. 30 billion yuan.
Three, investment direction
Relying on Luye Pharmaceutical, Yantai International Biomedicine and Health Industry Innovation Center, Yantai Branch of Shanghai Institute of Medicine, Yantai Institute of Translational Medicine of Tongji University, Shandong Kangnuo Shengshi Pharmaceutical Processing, Saichun Pharmaceutical Biotechnology, Baobas Rehabilitation Hospital, Yuhuayuan Companies and institutions such as the Elderly Apartment, Renna Fan Yantai Nursing Home in Germany, etc., are vigorously introducing production R&D and service projects in industries such as biomedicine, rehabilitation and elderly care, to create a domestic first-class characteristic industrial cluster.
1. Biomedicine industry. Focus on the introduction of tumors, immune system diseases, cardiovascular disease treatments, etc., develop long-acting injection microspheres, microcrystals, transdermal patches and other high-end preparations and new antibody drugs based on new therapeutic targets, and build long-acting and targeted high-end preparations And ADC, bifunctional antibody and other new antibody technology platforms. For diseases such as diabetes and viral infections, develop long-acting genetically recombinant protein drugs and new vaccines such as multi-linked multivalent vaccines, genetic engineering vaccines, viral vector vaccines, and nucleic acid vaccines.
2. Medical device industry. Focus on the introduction of in vitro diagnostic products with core technology and great clinical value, including high-throughput biochemical analysis, immunoassay, molecular diagnostic equipment and related reagents; support the development of medical hyperbaric oxygen chambers, air pressure chambers, medical oxygen production and other oxygen-related equipment And various new types of tissue repair materials for oral repair, skin repair, ligament repair, bone repair and nerve repair.
3. Rehabilitation and pension industry. Focus on introducing rehabilitation aids, compound health medical institutions, coastal health tourism, marine biological preparations, marine health foods, etc., to create a health industry development cluster that integrates production, life, and ecology.
4. High-tech pharmaceutical R&D and industrialization service outsourcing. Focus on the introduction of characteristic intermediates and APIs, high-end preparations, new antibodies, etc., to support the construction of a high-level, international comprehensive biomedical contract research and development and production service platform. Increase support for CAR-T immunotherapeutic drug development platform and antibody drug industrialized production process characterization and process verification (PC/PV) key common technology platforms.
Fourth, investment advantage
Yantai High-tech Industrial Development Zone has Shandong Peninsula National Independent Innovation Demonstration Zone, Shandong New and Old Kinetic Energy Conversion Comprehensive Experimental Zone Yantai Core Area, East Zone of China-Korea (Yantai) Industrial Park, National Torch Plan Marine Biology and Pharmaceutical Characteristic Industrial Base, and National Strategic There are 20 provincial and ministerial-level brands such as the pilot project of marine biology and pharmaceutical intellectual property cluster management in emerging industries, and the pilot of marine biological and pharmaceutical innovative industrial clusters. They have been recognized as advanced units of talent work in Shandong Province and have been awarded the work of the national "Haizhi Plan" The base has formed a good development trend of enterprise-led, platform-driven, and talent pooling.
1. Cluster of R&D institutions. The zone has 1 national key laboratory in the field of marine biology and medicine, 1 national-level enterprise technology center, and 5 provincial-level enterprise technology centers (engineering laboratories, research centers, and engineering technology research centers). The products cover biopharmaceuticals and medical care. Equipment, diagnostic reagents and vaccines, modern Chinese medicine, biological health products and other fields. It has 4 national technology business incubators, 1 national technology business incubator, 3 provincial technology business incubators, and 3 provincial technology business incubators to build an innovation and entrepreneurship platform for the development of high-tech enterprises and high-end talents in the district.
2. Complete infrastructure. Located in the core area of Yantai City, the 1-hour traffic circle covers railways, ports, and airports, and can directly communicate with major cities across the country and more than 100 countries and regions in the world. It has complete infrastructure and strong project carrying capacity. At present, a complete road network layout has been formed, with an independent water supply system, sufficient power supply, and complete sewage treatment facilities. The "seven connections and one leveling" have been realized, and the project has good carrying conditions.
3. Policy support and holding power. Promote "standard land" investment promotion, implement the "land acquisition and start-up model" approval, roll out the net land plan, and fully guarantee the land demand for industrial park projects. For projects that conform to the industry development orientation, such as the three categories of top 500 companies and global industry leaders, the implementation of "one matter, one discussion" will further increase support. Vigorously implement the "Blue Ocean Talent Plan" to provide high-level talents with convenient and efficient services in terms of settlement, children's enrollment, and medical security.
1. Location
The area is located in Muping Qinshui Industrial Park, East Zone of China-Korea (Yantai) Industrial Park Development Zone, starting from Lvlin Road in the west, to the high-speed rail line in the north, Donghai Road in the east, and Gongshang Avenue in the south, with a planned area of 10 square kilometers.
2. Development goals
Strive to introduce no less than 3 new biopharmaceutical companies by the end of 2022, with an industrial scale of more than 20 billion yuan; by the end of 2025, introduce more than 5 biopharmaceutical companies, with an industrial scale exceeding 50 billion yuan.
Three, investment direction
Through joint ventures, cooperation, sole proprietorship, technology introduction, etc., focus on the development of strategic emerging industries such as medical health and intelligent manufacturing.
1. In terms of industrial park cultivation: Promote the CSPC Biomedical High-tech Industrial Park with an investment of 3 billion yuan, and the Fengjin Biopharmaceutical Industrial Park with an investment of 1 billion yuan, and strive to build two tens of billions of industrial clusters in the middle of the "14th Five-year Plan" At the end of the "14th Five-Year Plan", a 50 billion-level industrial cluster will be built.
2. In terms of corporate recruitment: aiming at Fortune 500 companies such as Pfizer, Novartis, Roche, Merck, Sanofi, Canon Medical, etc., connecting with large pharmaceutical companies such as Luye Pharmaceuticals, Qilu Pharmaceuticals, Hengrui Pharmaceuticals, Xinshengyuan, and promoting Fuhai Pharmaceutical packaging materials And other supporting industry projects to accelerate the agglomeration development of the biomedical industry.
Fourth, investment advantage
The area is superimposed with national and provincial strategies such as the China-Korea (Yantai) Industrial Park, the new and old kinetic energy conversion comprehensive test zone, and has a variety of policies and market dividends, convenient transportation and complete supporting facilities. Vigorously promote the "standard land" model, clarify the investment, energy consumption, and environmental standards for the transfer of net land in the area, publicize and incorporate the land transfer conditions at one time, ensure that the land is acquired and start construction, and comprehensively improve the quality and efficiency of net land investment. Actively strive to include projects in the park into the key investment promotion project plans of provinces and cities, and make every effort to ensure the land demand for the project. For investment projects of Fortune 500 companies and industry leaders, the implementation of key projects will be discussed on a case-by-case basis.
